Ascentage Pharma Group International American Depository Shares (AAPG) is a publicly traded Healthcare sector company. As of May 21, 2026, AAPG trades at $19.86 with a market cap of $1.73B and a P/E ratio of 0.00. AAPG moved +5.00% today. Year to date, AAPG is -23.69%; over the trailing twelve months it is -18.26%. Its 52-week range spans $17.00 to $48.45. Analyst consensus is strong buy with an average price target of $41.56. Rallies surfaces AAPG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Ascentage Pharma to Showcase 17 Clinical Advances at EHA2026: Ascentage Pharma will present 17 clinical advances—eight via poster—at EHA2026 in Stockholm June 11–14. Presentations include updated efficacy and safety data for Olverembatinib (HQP1351) in chronic-phase CML and preliminary results for Lisaftoclax (APG-2575) in CLL/SLL.
| Metric | Value |
|---|---|
| Price | $19.86 |
| Market Cap | $1.73B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $48.45 |
| 52-Week Low | $17.00 |
| Volume | 83 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
6 analysts cover AAPG: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.56.